Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers

Abroad (travel likely)Recruiting

Conditions

Oligoprogression · Oligometastatic Disease · OligoProgressive Metastatic Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

BC Cancer - Surrey, Surrey, British Columbia, Canada
Contact: Study coordinator (Sarah Baker, MD, PhD, FRCPC) · sarah.baker1@bccancer.bc.ca · 604-930-4032

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

OligoProgressive Metastatic Disease · Hepatocellular Carcinoma (HCC) · Radiotherapy

Abroad (travel likely)RecruitingPHASE3

Jinan, China

COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study

Breast Cancer Invasive · Metastatic Cancer · Oligoprogressive

Abroad (travel likely)RecruitingPHASE2

Alkmaar, Netherlands · Amsterdam, Netherlands

Metastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate Cancer

Castration-resistant Prostate Cancer · Oligoprogressive

Abroad (travel likely)RecruitingPHASE3

Leuven, Belgium

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Oligometastatic Disease · Oligoprogression · Toxicity Due to Radiotherapy

Abroad (travel likely)Recruiting

Kelowna, Canada · Prince George, Canada